Mosquitoes

Aedes aegypti: Beyond the Black and White

One look at Aedes aegypti gives an immediate impression of its menacing nature. The telltale dark and white bands on the mosquito’s legs and other body parts bring a sense of foreboding and hardship. Sleek, silent, and stealthy, Ae. aegypti is the primary vector for several important, debilitating, and sometimes fatal human diseases including dengue, Zika virus, yellow fever, and chikungunya. The species is cause for mounting concern on many levels, as its biology, behavior, and ability to adapt have made Aedes aegypti one of the most pervasive and daunting public health challenges in the modern world.

The first mosquito ever associated with the spread of disease, Ae. aegypti is also the most studied of all mosquito species.1 From its humble beginnings in the African wild to a footprint that spans the globe, this durable and opportunistic insect has become a formidable opponent of vector control efforts worldwide.

Vector-borne Diseases & Climate Change

Climate change creates new risks, particularly in the United States, for human exposure to vector-borne diseases (VBDs) — diseases which are transmitted to humans through the bites of insects (referred to as vectors) that carry the disease-causing pathogens. Common vectors include mosquitoes, ticks, and flies.

Climate change creates new uncertainties about the spread of VBDs such as the Zika virus, dengue fever, malaria, and Lyme disease by altering conditions that affect the development and dynamics of the disease vectors and the pathogens they carry.

Study: Digitally Managed Larviciding

A new study has found that larval source management (LSM) – treating mosquito breeding habitats – can still be effective in malaria elimination operations, especially with the aid of new digital technologies. LSM has been replaced in Africa by long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), but these methods are becoming less effective due to mosquitoes’ growing resistance to insecticides.

Public Health in the Public Eye

Communicating the value of a vector control program. Securing much-needed funding. Informing the community about upcoming treatments. Answering complaints. Trying to change behavior. As if …

Top 5 Takeaways from Our Interview with Dr. Tracey McNamara

In mid-July, Valent BioSciences had the privilege of interviewing Dr. Tracey McNamara, DVM, DACVP, and Professor of Pathology in the College of Veterinary Medicine at …